WealthCollab’s DexCom DXCM Stock Holding History

WealthCollab’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92	Closed	-$6.19K	–	1046
2025 Q3	$6.19K	Hold	92	–	–	﹤0.01%	630
2025 Q2	$8.03K	Hold	92	–	–	﹤0.01%	541
2025 Q1	$6.28K	Hold	92	–	–	﹤0.01%	566
2024 Q4	$7.16K	Hold	92	–	–	﹤0.01%	515
2024 Q3	$6.17K	Buy	+92	New	+$7.55K	﹤0.01%	567

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WealthCollab's DXCM Position: Q4 2025 in Review

WealthCollab sold out of DexCom (DXCM) in Q4 2025, closing a stake of 92 shares — an estimated $6.19K sold.

WealthCollab first reported a position in DXCM in Q3 2024 and held it in 5 quarters. The position peaked at $8.03K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

WealthCollab reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
WealthCollab sold 92 DexCom shares in Q4 2025, an estimated $6.19K.
WealthCollab first reported a position in DexCom in Q3 2024 and held it in 5 quarters.
WealthCollab's DexCom position peaked at $8.03K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on WealthCollab's 13F filing for Q4 2025, filed 27 Jan 2026.